Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI.

Trial Profile

Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 14 Oct 2014

At a glance

  • Drugs Nortriptyline; Rabeprazole
  • Indications Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Nov 2011 Actual end date changed from May 2010 to Nov 2011 as reported by ClinicalTrials.gov (NCT00539240).
    • 18 Nov 2011 Actual end date changed from May 2010 to Nov 2011 as reported by ClinicalTrials.gov (NCT00539240).
    • 25 May 2011 Planned end date changed from 1 May 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov (NCT00539240).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top